Search Results

There are 357834 results for: content related to: Exploring the potential prognostic effect of various country-specific health service data on all-cause mortality using data from a large prospective study in schizophrenia

  1. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Article first published online : 8 JUN 2012, DOI: 10.1002/pds.3296

  2. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 980–990, Anaïs Lacasse, Mark A. Ware, Marc Dorais, Hélène Lanctôt and Manon Choinière

    Article first published online : 24 JUN 2015, DOI: 10.1002/pds.3820

  3. Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model

    Pharmacoepidemiology and Drug Safety

    Javier Cid Ruzafa, Evie Merinopoulou, Rebecca F. Baggaley, Pamela Leighton, Winifred Werther, Diana Felici and Andrew Cox

    Article first published online : 19 JAN 2016, DOI: 10.1002/pds.3927

  4. Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 4, April 2015, Pages: 435–445, Mir M. Ali, Catherine E. O'Brien, Mario A. Cleves and Bradley C. Martin

    Article first published online : 12 FEB 2015, DOI: 10.1002/pds.3758

  5. Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 489–497, Supinya Dechanont, Sirada Maphanta, Bodin Butthum and Chuenjid Kongkaew

    Article first published online : 10 MAR 2014, DOI: 10.1002/pds.3592

  6. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1155–1172, Charles E. Leonard, Cristin P. Freeman, Craig W. Newcomb, Peter P. Reese, Maximilian Herlim, Warren B. Bilker, Sean Hennessy and Brian L. Strom

    Article first published online : 9 AUG 2012, DOI: 10.1002/pds.3329

  7. Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 12, December 2015, Pages: 1259–1270, Diogo Mendes, Carlos Alves and Francisco Batel-Marques

    Article first published online : 16 SEP 2015, DOI: 10.1002/pds.3874

  8. A new “Comparative Effectiveness” assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazone

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 1, January 2013, Pages: 86–97, Richard Tannen, Dawei Xie, Xingmei Wang, Menggang Yu and Mark G. Weiner

    Article first published online : 15 OCT 2012, DOI: 10.1002/pds.3360

  9. Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 494–506, Christopher G. Rowan, Steven M. Brunelli, Jeffrey Munson, James Flory, Peter P. Reese, Sean Hennessy, James Lewis, Daniel Mines, Jeffrey S. Barrett, Warren Bilker and Brian L. Strom

    Article first published online : 16 MAR 2012, DOI: 10.1002/pds.3199

  10. Persistence of racial disparities in prescription of first-generation antipsychotics in the USA

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 11, November 2015, Pages: 1197–1206, Thomas B. Cook, Gloria M. Reeves, James Teufel and Teodor T. Postolache

    Article first published online : 1 JUL 2015, DOI: 10.1002/pds.3819

  11. Selection bias in pharmacy-based patient surveys

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 2, February 2014, Pages: 128–139, P Frisk, S Kälvemark-Sporrong and B Wettermark

    Article first published online : 30 AUG 2013, DOI: 10.1002/pds.3488

  12. The extent and correlates of community-based pharmaceutical opioid utilisation in Australia

    Pharmacoepidemiology and Drug Safety

    Louisa Degenhardt, Natasa Gisev, Elena Cama, Suzanne Nielsen, Briony Larance and Raimondo Bruno

    Article first published online : 19 JAN 2016, DOI: 10.1002/pds.3931

  13. A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 12, December 2015, Pages: 1321–1333, Amy Peacock, Louisa Degenhardt, Briony Larance, Elena Cama, Nicholas Lintzeris, Robert Ali and Raimondo Bruno

    Article first published online : 30 SEP 2015, DOI: 10.1002/pds.3883

  14. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 2, February 2015, Pages: 176–186, Florian Meier, Renke Maas, Anja Sonst, Andrius Patapovas, Fabian Müller, Bettina Plank-Kiegele, Barbara Pfistermeister, Oliver Schöffski, Thomas Bürkle and Harald Dormann

    Article first published online : 17 JUN 2014, DOI: 10.1002/pds.3663

  15. Development and validation of algorithms to identify acute diverticulitis

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 1, January 2015, Pages: 27–37, Aniket Kawatkar, Li-Hao Chu, Rajan Iyer, Linnette Yen, Wansu Chen, M. Haim Erder, Paul Hodgkins and George Longstreth

    Article first published online : 25 SEP 2014, DOI: 10.1002/pds.3708

  16. Design of a score to identify hospitalized patients at risk of drug-related problems

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 9, September 2014, Pages: 923–932, Olatz Urbina, Olivia Ferrández, Santiago Grau, Sonia Luque, Sergi Mojal, Monica Marin-Casino, Javier Mateu-de-Antonio, Alexia Carmona, David Conde-Estévez, Merce Espona, Elena González, Marta Riu and Esther Salas

    Article first published online : 10 MAY 2014, DOI: 10.1002/pds.3634

  17. Trends in the outpatient treatment of atrial fibrillation in the USA from 2001 to 2010

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 539–547, Amarsinh M. Desai, Teresa M. Cavanaugh, Vibha C. A. Desai, Pamela C. Heaton and Christina M. L. Kelton

    Article first published online : 12 MAR 2014, DOI: 10.1002/pds.3605

  18. Association between benzodiazepine use and exacerbations and mortality in patients with asthma: a matched case-control and survival analysis using the United Kingdom Clinical Practice Research Datalink

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 8, August 2015, Pages: 793–802, Georgina Nakafero, Robert D. Sanders, Jonathan S. Nguyen-Van-Tam and Puja R. Myles

    Article first published online : 27 MAY 2015, DOI: 10.1002/pds.3799

  19. Validity of maternal and infant outcomes within nationwide Medicaid data

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 646–655, Kristin Palmsten, Krista F. Huybrechts, Mary K. Kowal, Helen Mogun and Sonia Hernández-Díaz

    Article first published online : 16 APR 2014, DOI: 10.1002/pds.3627

  20. Association between beta-interferon exposure and hospital events in multiple sclerosis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 11, November 2014, Pages: 1213–1222, Charity Evans, Feng Zhu, Elaine Kingwell, Afsaneh Shirani, Mia L. van der Kop, John Petkau, Paul Gustafson, Yinshan Zhao, Joel Oger and Helen Tremlett

    Article first published online : 21 JUN 2014, DOI: 10.1002/pds.3667